242 filings
8-K
KV+A
KV Pharmaceutical Co
6 Nov 13
Departure of Directors or Certain Officers
12:00am
8-K
KV+A
KV Pharmaceutical Co
18 Oct 13
KV Pharmaceutical Company Appoints Two New Board Members
12:00am
8-K
KV+A
KV Pharmaceutical Co
4 Oct 13
KV Pharmaceutical Company Appoints Former Wyeth Pharmaceuticals President, Joe Mahady to Chairman of the Board
12:00am
8-K
KV+A
KV Pharmaceutical Co
23 Sep 13
United States Bankruptcy Court Southern District of New York
12:00am
8-K/A
KV+A
KV Pharmaceutical Co
23 Sep 13
KV Pharmaceutical Company Completes Reorganization and Successfully Emerges from Chapter 11 with $375 Million Recapitalization
12:00am
8-K
mskwq4uuj
23 Sep 13
KV Pharmaceutical Company Completes Reorganization and Successfully Emerges from Chapter 11 with $375 Million Recapitalization
12:00am
8-K
q56 euwcec46
5 Sep 13
United States Bankruptcy Court Southern District of New York
12:00am
8-K
ljxgq7pzg1g1lj8a jf
21 Aug 13
Regulation FD Disclosure
12:00am
8-K
fgwv3pfg81h
8 Aug 13
Ther-Rx Corporation Announces the Availability of Clindesse® (Clindamycin Phosphate) Vaginal Cream, 2% for Prescribing
12:00am
8-K
p3ydhgstwvc5d
19 Jul 13
Regulation FD Disclosure
12:00am
8-K
58ycvl883m0c 3bb
27 Jun 13
United States Bankruptcy Court Southern District of New York
12:00am
8-K
qr9iitqcg
21 Jun 13
Regulation FD Disclosure
12:00am
8-K
5ak rz8e7gy
20 May 13
Regulation FD Disclosure
12:00am
8-K
gm06mf6gfepiy u4ap
25 Apr 13
Other Events
12:00am
8-K
h9ufn4 vdl7c
19 Apr 13
Regulation FD Disclosure
12:00am
8-K
w1ncs 8vqa6hmmz
21 Mar 13
Monthly Operating Report for the Period
12:00am
8-K
cj3k0nu9h782rwxnlc1
20 Feb 13
Regulation FD Disclosure
12:00am
8-K
oodcu 17lic
11 Feb 13
Regulation FD Disclosure
12:00am
8-K
930y76j9mkucy
29 Jan 13
Regulation FD Disclosure
12:00am
8-K
fo9xsllnncyhfy
22 Jan 13
Monthly Operating Report for the Period
12:00am